P2rx7 genetic deletion in PS19 tauopathy mice

PRIMARY OUTCOME

Brain atrophy, tau accumulation, and cognitive impairment

EXPECTED OUTCOMES

1. The intervention targeting P2rx7 shifts Brain atrophy, tau accumulation, and cognitive impairment in the predicted direction relative to the matched control arm. 2. Secondary disease-relevant readouts in Alzheimer's disease/tauopathy remain directionally concordant with the primary endpoint rather than showing isolated single-assay effects. 3. The effect persists after adjustment for baseline covariates, batch effects, or repeated-measures structure used in the study design.

SUCCESS CRITERIA

- Prespecified primary endpoint (Brain atrophy, tau accumulation, and cognitive impairment) improves versus control with p < 0.05 or an equivalent corrected threshold used by the study. - The effect size is biologically meaningful and reproduced across technical/biological replicates or the validation subset. - Safety, data quality, and missingness remain within protocol-defined bounds so the result is interpretable rather than driven by attrition or assay failure.

PROTOCOL

1. Establish PS19 tauopathy mice cohorts for Alzheimer's disease/tauopathy and predefine inclusion, exclusion, and quality-control criteria before intervention. 2. Apply the experimental manipulation described for P2rx7, alongside matched control or comparator arms, and document dose, exposure window, and sample timing in a locked protocol log. 3. Measure Brain atrophy, tau accumulation, and cognitive impairment together with orthogonal secondary readouts such as molecular, imaging, behavioral, or safety endpoints that are appropriate to the title and study design. 4. Use blinded outcome assessment where feasible, prespecified statistical analysis, and replicate the core readout across biological replicates or an independent validation subset. 5. Interpret results against the baseline study rationale: This experiment examined the effects of genetic deletion of P2rx7 in PS19 tauopathy mice, a mouse model of Alzheimer's disease. Researchers compared PS19 mice with intact P2rx7 to those with genetic deletion of P2rx7, measuring brain atrophy, tau accumulation,

LINKED HYPOTHESES

HTML iframe

<iframe src="http://scidex.ai/artifact/exp-1cc19685-9901-4bc4-a1f3-bc07d1aae7f0?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>

Markdown link

[P2rx7 genetic deletion in PS19 tauopathy mice](http://scidex.ai/artifact/exp-1cc19685-9901-4bc4-a1f3-bc07d1aae7f0)

Direct URL

http://scidex.ai/artifact/exp-1cc19685-9901-4bc4-a1f3-bc07d1aae7f0

Preview